B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OR51E2

MOLECULAR TARGET

olfactory receptor family 51 subfamily E member 2

UniProt: Q9H255NCBI Gene: 812856 compounds

OR51E2 (olfactory receptor family 51 subfamily E member 2) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OR51E2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Ketoglutaric Acids0.691
2Glycine0.691
3Bradykinin0.691
4Epitestosterone0.691
5Palmitic Acid0.691
6Urea0.691

About OR51E2 as a Drug Target

OR51E2 (olfactory receptor family 51 subfamily E member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented OR51E2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OR51E2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.